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The preparation, characterization and application of NaYF4:Yb
3+, Tm3+–NaYF4:Yb
3+, Er3+ core–shell upconversion
nanocrystals (UCNPs) with multiple emission peaks (e.g. 539, 654 and 802 nm) have been demonstrated in this
work. The monodisperse nanocrystals were prepared via a modified thermal decomposition synthesis. The
resulting UCNPs were B31 nm in diameter with the lanthanide ions Tm3+ and Er3+ doped in the core and the
shell, respectively. Under the laser diode excitation at 980 nm, these core–shell nanocrystals give strong
upconversion emissions from the visible to near-infrared (NIR) region. By coating a PEG–phospholipid (PP) layer
on the surface of the nanocrystals, the as-prepared UCNPs were favorably endowed with good water solubility
for the potential biological applications. Here, a photosensitizer drug of Chlorin e6 (Ce6), which has maximum
absorption that overlaps with the red emission of UCNPs, was loaded on these PP-coated UCNPs (UCNP@PP)
by physical adsorption. The activity of the Ce6-loaded UCNP@PP (UCNP@PP–Ce6) in photodynamic therapy of
cancer cells in vitro has been fully investigated in this work. Our results indicated that these multifunctional
UCNP@PP–Ce6 nanoparticles have efficient NIR-to-NIR upconversion luminescence and photodynamic therapy
capabilities, which could be potentially employed as a theranostic platform for cancer treatment.
1. Introduction
In recent years, multifunctional nanomaterials have attracted great
interest in biomedical studies due to their capabilities to integrate
various functionalities, such as targeting, imaging, drug delivery
and therapy, into one single entity.1–13 Among them, lanthanide
(Ln3+)-doped upconversion nanoparticles (UCNPs) are promising
candidates as a highly efficient diagnosis and therapy platform
owing to their attractive features: (1) their absorbance at near-
infrared (NIR) wavelengths allows for tissue penetration to a depth
of centimeters and reduces autofluorescence from biological
tissue;14–18 (2) their emitting wavelength can be fine-tuned by
changing the host matrix and lanthanide dopants;19,20 (3) UCNPs
possess high quantum yields, narrow emission peaks, large Stokes
shifts, low toxicity, good chemical stability and photostability.23
Due to these promising advantages of the UCNPs, intensive
investigations have been carried out to explore the preparation of
varieties of UCNPs and their applications in detection, bioimaging,
therapy and optical limiting etc.10–31 Especially, as the ‘‘optical
transmission window’’ of the biological tissues is in the NIR range
(700–1000 nm), where blood and tissue are maximally transparent
and the NIR light can penetrate several centimeters in depth, the
UCNPs with NIR excitation and NIR emission are greatly favoured
for both in vitro and in vivo imaging. As a result, different
Tm3+-doped UCNP platforms with NIR-to-NIR upconversion
luminescence have been developed previously for high contrast
and highly penetrating in vivo fluorescence imaging.27,28,32
The prominent optical properties of UCNPs also break a new
path for current PDT. It has been reported that the NIR light-
triggered photodynamic therapy (PDT) could effectively reduce
the photosensitivity to ambient light and improve the safety of
PDT.30 The NIR excitation of UCNPs permits deeper tissue
penetration than visible light, which is suitable for the PDT of deep
tissue cancer.33 In addition, the visible upconversion luminescence
from the excited UCNPs can overlap the maximum absorption
of many available photosensitizers (PSs). Therefore, this light
can be utilized to activate surrounding PSs to produce reactive
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oxygen species to kill cancer cells.30,33–43 Zhang and coworkers
first reported the representative application of NaYF4 UCNPs in
PDT.34 Later, several groups have modified UCNPs by coating a
silica layer or an amphiphilic polymer for synergistic optical, MRI
imaging and PDT applications.30,33,35–43 However, the previous
investigation of upconverting nanoparticles in both imaging and
PDT is mainly based on the Yb3+/Er3+ co-doped NaYF4 or NaGdF4
UCNPs.30,33–43 As Yb3+/Er3+ co-doped NaYF4 usually gives a bright
green emission (around 550 nm) along with a weak dark red
emission (around 660 nm), its tissue imaging applications are
greatly restricted owing to the shallow penetration depth of green
light and the low intensity of red emission whose signal is usually
too weak to be detected.24,29 Therefore, it is highly desired to
synthesize Er3+ and Tm3+co-doped UCNPs with multiple emissions
that can be applied for both NIR imaging and PDT.
Herein we report the use of a thermal decomposition
method to synthesize NaYF4:Yb
3+, Tm3+–NaYF4:Yb
3+, Er3+ core–
shell nanocrystals with Tm3+ and Er3+ doped in the core and the
shell, respectively. The morphologies of the core–shell nanocrystals
were characterized using SEM and TEM. A PEG–phospholipid layer
was then coated on the surface of UCNPs (UCNPs@PP) to render
them water-soluble. The UCNPs displayed strong NIR-to-visible
(500–700 nm) and NIR-to-NIR (750–850 nm) upconversion
fluorescence under the excitation of the 980 nm laser. The
visible emission can be used to activate photosensitizers for
PDT and the NIR emission can be utilized for image tracking.
The application of the UCNPs@PP nanoparticles as carriers for
photosensitizer Ce6 in the photodynamic destruction of cancer
cells in vitro was investigated in detail.
2. Experimental section
2.1 Chemicals
Re2O3 (Re = Y, Yb, Er and Tm, 99.99%), trifluoroacetic acid
(CF3COOH, 99%), sodium trifluoroacetate (CF3COONa, 98%),
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT)
and 1,3-diphenylisobenzofuran (DPBF) were purchased from
Sigma-Aldrich. Oleic acid (technical grade, 90%) and 1-octadecene
(technical grade, 90%) were purchased from Alfa Aesar. 1,2-Dis-
tearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene
glycol)-2000] (mPEG-2000 PE, PP) was obtained from Avanti Polar
Lipids, Inc. Chlorin e6 (Ce6, 495%) was purchased from Frontier
Scientific, Inc. All the Re(CF3COO)3 precursors were prepared by
dissolving the corresponding rare-earth oxides in CF3COOH–water
(1 : 1) solutions and heating at the refluxing temperature until
the solution became clear. All other chemicals were of analytical-
reagent grade and used without further purification. The water
used in all experiments was ultrapure.




The synthesis was carried out under standard oxygen-free
conditions. In a typical procedure, the NaYF4:Yb
3+, Tm3+ core
solution was prepared by mixing 1.25 mmol of Re(CF3COO)3
(Y : Yb : Tm = 69.5% : 30% : 0.5%) and 1.25 mmol of CF3COONa
in 2.5 ml of 1-octadecene and 5 ml of oleic acid (denoted A).
The NaYF4:Yb
3+, Er3+ shell solution was prepared by mixing
1.25 mmol of Re(CF3COO)3 (Y : Yb : Er = 78% : 20% : 2%) and
1.25 mmol of CF3COONa in another reaction vessel with 2.5 ml
of 1-octadecene and 5 ml of oleic acid (denoted B). 15 ml of
1-octadecene and 10 ml of oleic acid were then prepared in a
100 ml three-neck round bottom flask (denoted C). A and C were
heated to 125 1C under an argon blanket with stirring for 30 min to
remove residual water and oxygen. The solution of C was then
heated to 305 1C under argon and maintained at this temperature.
The solution of A at 125 1C was then transferred dropwise into C
using a syringe pump at a flow rate of 1.0 ml min1 (KDS100, USA).
After completing the addition, the reaction mixture was heated to
320 1C and kept at this temperature for 30 min to form the
NaYF4:Yb
3+, Tm3+ core. Then the shell precursors (solution B) at
125 1C were injected (at a rate of 1.0 ml min1) into the above
reaction vessel C which contains the core nanoparticles. While
delivering B, C was maintained at 305 1C. After completing the
addition, the reaction mixture was heated to 320 1C and kept at this
temperature for 30 min under argon. Subsequently, solution C was
allowed to cool to room temperature. Nanocrystals were precipitated
out by adding ethanol and were isolated via centrifugation
(12 000 rpm, 6 min). The products were washed with a 1 : 8
cyclohexane–ethanol (V/V) mixture three times to remove
any impurities. The as-prepared nanocrystals could be easily
re-dispersed in cyclohexane or chloroform.
The synthetic process of the core-only nanocrystals
(NaYF4:Yb
3+, Tm3+) was similar to that of the core–shell nanocrystals.
Lanthanide trifluoroacetate precursors and sodium trifluoroacetic
acid (in stoichiometric quantities) were dissolved in 2.5 ml of
1-octadecene and 5.0 ml of oleic acid (solution A). Following
degassing, the solution was injected into the reaction vessel
which contains 25 ml of degassed oleic acid and 1-octadecene
(solution B) at 305 1C under Ar and heated for 30 min at 320 1C.
All subsequent steps were identical.
2.3 Modification of UCNPs with PEG–phospholipids
(UCNP@PP)
Briefly, 1 ml of UCNPs dispersed in chloroform (10 mg ml1)
was mixed with 2 ml of mPEG-2000 PE (PP) in chloroform
(10 mg ml1) and stirred for 2 h. Then a lab rotary evaporator with
a water bath at 60 1C was used to evaporate the solvent and the
residue was readily dispersed in water. The resulting dispersion
was filtered through a 0.22 mm cellulose acetate syringe filter to
remove large aggregates and kept at 4 1C for further use.
2.4 Loading Chlorin e6 on UCNP@PP (UCNP@PP–Ce6)
The loading of Chlorin e6 onto the UCNP@PP was carried out
by mixing Ce6 (0.8 mmol) with UCNP@PP (0.5 mg ml1) in
phosphate buffer solution (PBS, pH = 7.4) for 24 h at room
temperature. Free Ce6 was removed by centrifugation at
14 000 rpm for 10 min and washed 3 times with PBS buffer.
The formed composite was re-dispersed in PBS and stored at
4 1C. A detailed scheme for the preparation of UCNP@PP–Ce6
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The concentrations of Ce6 loaded onto UCNP@PP were
determined by the absorbance at 404 nm with the UCNP@PP
as a blank reference.
2.5 Determination of singlet oxygen
Singlet oxygen production was determined using 1,3-diphenyl-
isobenzofuran (DPBF) as a chemical 1O2 probe, which reacted
irreversibly with 1O2 to cause a decrease in the DPBF absorption
intensity at about 400 nm.44 In a typical experiment, 30 ml of
DPBF (1.5 mg ml1 in acetonitrile) was added into a solution of
UCNP@PP–Ce6 in acetonitrile (2 ml). The solutions were then
irradiated with a 980 nm laser for 30 min, and the absorption
intensity of DPBF at 420 nm was recorded at given time intervals.
UCNP@PP in acetonitrile mixed with DPBF was used as the
control experiment.
2.6 Cellular experiments
2.6.1 Cell culture. The human hepatoma cells (QGY-7703),
human hepatocytes (QSG-7701) and HeLa cells were obtained
from the cell store room of Chinese Academy of Science. Cells
were grown in normal RPMI-1640 culture medium with 10%
calf serum, 100 U ml1 penicillin and 100 mg ml1 streptomycin
at 37 1C, in an incubator with a 5% CO2 atmosphere.
2.6.2 Cytotoxicity of UCNP@PP–Ce6. The in vitro cytotoxi-
cities of UCNP@PP–Ce6 to normal cells and cancer cells were
evaluated using a standard methyl thiazolyl tetrazolium (MTT)
assay. Briefly, the QGY-7703 and QSG-7701 cells were seeded
into 96-well cell-culture plates (Nunct) at B104 per well and
incubated for 24 h at 37 1C under 5% CO2. Various concentra-
tions of UCNP@PP–Ce6 (0, 50, 100, 200, 500 mg ml1, diluted in
the RPMI 1640 media) were then added to the wells. The cells
were further incubated for 12 h. Subsequently, the MTT solution
(25 ml, 5 mg ml1) was added to each well and incubated for an
additional 4 h at 37 1C. Then the formazan product was
dissolved in 150 ml dimethylsulfoxide (DMSO) solution. After
10 min, the absorbance at 490 nm for each well was recorded on
a Tecan Infinite M 200 monochromator-based multifunction
microplate reader. The corresponding nanoparticles with cells
but not treated by MTT were used as controls.
2.6.3 Uptake of UCNP@PP–Ce6 by cells. To test the uptake
of UCNP@PP–Ce6 nanoparticles by cells, HeLa cells were
chosen and cultured in 35 mm culture dishes for 24 h. Then the
culture medium was replaced by medium containing 200 mg ml1
UCNP@PP–Ce6 nanoparticles. After 4 h incubation, the cells were
washed three times with the PBS buffer. Confocal fluorescence
imaging was performed using an Olympus Fluoview 1000 laser-
scanning microscope and a 100 oil-immersion objective lens. A
405 nm laser was used to excite the nanoparticles, and the fluores-
cence of Ce6 was collected in a range of 600–750 nm.
2.6.4 In vitro photodynamic therapy. For the photodynamic
cancer cell killing, QGY-7703 was seeded onto a 24-well plate
with a density of 105 cells per well and incubated for 24 h. Then
the medium was replaced by cell medium (0.5 ml per well)
containing 100 mg ml1 of UCNP@PP–Ce6, UCNP@PP, or free
Ce6. After incubation for 12 h, the cells were washed with PBS
three times to remove the unbound nanoparticles. Then 0.5 ml
PBS was added and the cells were exposed to a 980 nm laser with
a power density of 1.5 W cm2 for 5 min, respectively. After
staining with trypan blue, the optical imaging was performed
using the fluorescence microscopy.
2.7 Characterization
The size and morphologies of nanoparticles were determined at
300 kV using a TECNAI F-30 high-resolution transmission
electron microscope. Energy-dispersive X-ray analysis (EDXA)
of the samples was also performed during high-resolution TEM
measurements. X-ray diffraction (XRD) measurements were
recorded on a PANalytical X’pert PRO diffractometer using Cu
Ka radiation, operating at 40 kV and 30 mA. UV-Visible (UV-Vis)
absorption spectra were obtained using a UV 2550 spectro-
photometer. The upconversion luminescence emission spectra
were recorded on a USB 2000 VIS-NIR spectrometer (Ocean Optics),
using an external 0–5 W adjustable 980 nm semiconductor laser
(BWT Beijing Ltd) as the excitation source. Dynamic light
scattering (DLS) and zeta potential experiments were carried
out on a Nano-ZS (Malvern Instruments).
3. Results and discussion
3.1 Synthesis and characterization of NaYF4:Yb
3+, Tm3+–
NaYF4:Yb
3+, Er3+ core–shell nanocrystals
The NaYF4:Yb
3+, Tm3+–NaYF4:Yb
3+, Er3+ core–shell nanocrystals
(UCNPs) were prepared using a modified thermal decomposition
process.18,45,46 Briefly, the core precursors (the lanthanide (Y, Yb
and Tm) trifluoroacetate and sodium trifluoroacetate) dissolved
in a small amount of 1-octadecene and oleic acid were firstly
injected using a syringe pump into a hot solution of oleic acid
and 1-octadecene. After the NaYF4:Yb
3+, Tm3+ core nanocrystals
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were formed under a certain temperature, the shell precursors
were also transferred dropwise into the hot reaction flask in




nanocrystals. A more detailed description of the synthetic
procedure is given in the Experimental section.
Fig. 1a and b are the typical SEM and TEM images of the
resulting UCNPs. It can be seen from the TEM image that the
synthesized particles are approximately 31 nm in diameter
(Fig. 1c) and appear to be hexagonal in shape. The size is larger
than that of the NaYF4:Yb
3+, Tm3+ core nanocrystals which had
a mean particle diameter of 23 nm (Fig. S1, ESI†). From the
difference in particle sizes between the core-only nanoparticles
and core–shell nanoparticles, it is thought that the observed
increase in size of the core–shell nanocrystals is attributed to
the growth of the NaYF4:Yb
3+, Er3+ shell around the core. The
crystalline structure of the products was further characterized
using high-resolution TEM (HRTEM) and X-ray diffraction (XRD)
analysis. HRTEM analysis of a single particle demonstrated that
the distance between the adjacent fringes was 0.31 nm, which
corresponds to the d-spacing for the (111) lattice plane in the
cubic NaYF4 structure.
45–47 The sharp peaks in the XRD pattern
(Fig. 1d) indicate the good crystallization of the prepared nano-
crystals. All the diffraction peaks could be well indexed to the
JCPDS card No. 6-0342 of the standard cubic structure NaYF4, and
no peaks from other phases or impurities were observed. In
addition, EDX analysis showed the presence of Y, Yb, Tm and
Er in the NaYF4:Yb
3+, Tm3+–NaYF4:Yb
3+, Er3+ core–shell nanocrys-
tals, whilst there was no signal for Er in the sample of NaYF4:Yb
3+,




nanocrystals were obtained, which is very beneficial for
obtaining bright luminescence.
3.2 Upconversion luminescence properties of the core–shell
nanocrystals
The upconversion luminescence spectrum under the excitation
of a continuous wave (CW) laser at 980 nm for NaYF4:Yb
3+,
Tm3+–NaYF4:Yb
3+, Er3+ core–shell nanocrystals presented in
Fig. 2a shows multiple emission bands ranging from visible
to NIR. The emission peaks at 520, 539, and 654 nm are assigned
to Er3+ transitions from energy levels 2H11/2,
4S3/2 and
4F9/2 to the
4I15/2 ground state, respectively. The intense NIR emission at
802 nm is attributed to Tm3+ transition from 3H4 to
3H6. The
dependence of the logarithm of the pumping power on the
logarithm of the upconversion emission intensity is further
investigated and shown in Fig. 2b. Both the slopes for the red
and green emissions of Er3+ and the 3H4 -
3H6 emission of
Tm3+ are about 2, indicating a two-photo process, which are in
agreement with data reported earlier.46
The prominent multiple emission bands of core–shell nano-
crystals make them potential candidates for multifunctional
bio-applications. It should also be noted that the luminescence
of the core–shell nanoparticles was more intense than that of their
co-doping counterparts (Fig. S3, ESI†). The visible emission can be
utilized to indirectly excite photosensitizers for photodynamic
therapy (PDT), while the NIR-to-NIR emission, which is located at
the biological window, can be used for both imaging diagnosis and
as a reference of fluorescence change. In the following work, we
explored the application of the nanocrystals in PDT in detail.
3.3 PEG–phospholipid functionalization and photosensitizers




Due to the as-prepared NaYF4:Yb
3+, Tm3+/NaYF4:Yb
3+, Er3+
core–shell nanocrystals bearing hydrophobic surface ligands
of oleic acid (OA), it is unsatisfactory for their application in
biomedical field. Amphiphilic poly(ethylene glycol)-conjugated
phospholipid (DSPE-PEG 2000) was chosen to transfer these
Fig. 1 (a) SEM and (b) TEM images of the NaYF4:Yb
3+, Tm3+–NaYF4:Yb
3+,
Er3+ core–shell nanocrystals (UCNPs). Inset: high-resolution TEM image of (b).
(c) Histogram of the particle sizes obtained from TEM images of B200 nano-
crystals. (d) XRD patterns of the core–shell nanocrystals (UCNPs) and the standard
patterns of pure cubic-phase NaYF4 (JCPDS No. 06-0342, red line).
Fig. 2 (a) Emission spectra of UCNPs in cyclohexane upon excitation using a
980 nm laser diode. (b) Power dependence of the upconversion emissions of UCNPs
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hydrophobic UCNPs into the aqueous phase. The successful
DSPE-PEG 2000 coating on the surface of the UCNPs was verified
using FTIR spectra. As shown in Fig. 3a, both of the oleic acid-coated
UCNPs and DSPE-PEG 2000-coated sample (UCNP@PP) demon-
strated a broad absorption band at around 3438 cm1, which
corresponds to the O–H stretching vibration. Due to a large number
of CH2 groups in the DSPE-PEG coating, the IR peaks at around
2900 cm1 were significantly increased in the UCNP@PP sample.
In addition, some additional peaks from 1000 to 1400 cm1 in the
UCNP@PP sample were likely owing to the stretching vibrations of
the C–O bond in PEG (Fig. S4, ESI†).
After surface modification, on one hand, the biocompatible,
hydrophilic PEG groups of DSPE-PEG 2000 extend outward,
rendering the UCNPs dispersible in water (inset of Fig. 3b). The
size distribution of UCNP@PP in aqueous solution measured
using dynamic light scattering (DLS) was about 51 nm (Fig. 3b).
The increase in size compared with that of UCNPs (B31 nm) is due
to the PEG–phospholipid shell. Also, after the surface modification
of DSPE-PEG 2000, the UCNP@PP still retained a strong upconver-
sion luminescence in aqueous solution (inset of Fig. 3b). On the
other hand, the hydrophobic layer (composed of oleic acid and
phospholipid) on top of the UCNP surface and beneath the PEG–
phospholipid coating also endows the UCNP@PP as a functional
carrier to load hydrophobic chemotherapeutic drugs or photosen-
sitizers (PSs) for cancer cells. For the application of UCNPs in PDT,
the maximum absorption peak of loading PSs should match the
UCNPs emission well which affords the effective resonance energy
transfer from UCNPs to PSs. Chlorin e6 (Ce6), a promising photo-
sensitizer molecule for experimental photodynamic therapy with
Q-band maximum absorption (650–700 nm) matching the
654 nm red emission of UCNP@PP, is loaded into the hydro-
phobic layer of UCNP@PP by physical absorption through
simple mixing. The hydrophobicity of Ce6 facilitates its encap-
sulation into the inner layer of UCNP@PP.
As shown in Fig. 4a, the prepared UCNP@PP–Ce6 complex
formed a yellow-green clear solution. The successful encapsula-
tion of Ce6 into the UCNP@PP nanoparticles was also evidenced
by the UV/Vis absorption spectra of UCNP@PP–Ce6, in which the
characteristic Ce6 absorptions at about 400 nm and 650–700 nm
were clearly identified (Fig. 4b). According to the calibration
curve of the UV-Vis absorption spectra of free Ce6 at 404 nm,
the loading efficiency of Ce6 onto UCNP@PP in phosphate
buffers (PBS, pH 7.4) was approximately 23% (w/w). In addition,
after loading Ce6 into the nanoparticles, both the green and red
emissions of UCNP@PP are strongly quenched, while the NIR
(803 nm) band was not, owing to the resonance energy transfer
from the UCNPs to the encapsulated Ce6 (Fig. 4c). The release of
Ce6 from the UCNP@PP–Ce6 nanoparticles was also investi-
gated in PBS solution (pH 7.40), sample solutions were taken on
different days and centrifuged. The supernatants were subjected
to UV-Vis absorption measurements. The results showed that
Ce6 was not leaked from the UCNP@PP–Ce6 nanoparticles
incubated in the PBS solution for up to seven days (Fig. 4d),
suggesting that the nanoparticles are very stable against PS
leaching. The excellent NIR emission and good stability against
PS leakage of these nanoparticles make them a good candidate
for various biological applications.
3.4 Determination of singlet oxygen
Singlet oxygen (1O2) is a highly reactive oxygen species and is
believed to play a key role in the PDT. In this study, the singlet
oxygen (1O2) production of UCNP@PP–Ce6 under the irradia-
tion of a 980 nm laser was evaluated by an indirect chemical
method using 1,3-diphenylisobenzofuran (DPBF). DPBF has an
absorption peak at 420 nm and the intensity will decrease after
interacting with singlet oxygen. As shown in Fig. 5, in the
presence of UCNP@PP–Ce6, the absorption intensity of DPBF
at 420 nm showed a significant decrease with the irradiation
time (line 2), suggesting a high efficiency in generation of
reactive 1O2. In contrast, the change in the absorption intensity
Fig. 3 (a) FTIR spectra of OA-UCNP (black curve) and UCNP@PP (red curve).
(b) The size distribution of UCNP@PP nanoparticles in water. Inset: photographs
of UCNP@PP nanoparticles in PBS under the ambient light and under a 980 nm
laser excitation.
Fig. 4 (a) Photographs of UCNP@PP–Ce6 under ambient light (left) and under
980 nm diode laser irradiation (right). (b) UV-Vis absorption spectra of Ce6,
UCNP@PP and UCNP@PP–Ce6 in PBS buffer (pH 7.40). (c) Upconversion lumines-
cence spectra of UCNP@PP (black curve) and UCNP@PP–Ce6 (red curve). (d) The
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of DPBF was negligible in the absence of Ce6 (line 1). These
results indicated that Ce6 was effectively activated by the emission
from UCNPs and in turn caused the generation of singlet oxygen.
Therefore, we investigated these Ce6-encapsulated UCNP@PP
particles as a new PDT drug carrier in NIR-induced tumor therapy.
3.5 Cytotoxicity study and cell uptake
The cytotoxicity of these nanoparticles was first checked. The
relative cell viabilities of human hepatoma cells (QGY-7703)
and human hepatocytes (QSG-7701) incubated at different
concentrations of UCNPs@PP–Ce6 for 12 h were measured
using MTT assay. As shown in Fig. 6a, more than 70% of the
cells survived after the co-incubation with 500 mg ml1
UCNP@PP–Ce6 for 12 h, indicating that these nanoparticles
are highly biocompatible. To monitor the intracellular uptake
of Ce6 loaded UCNP@PP, HeLa cells were incubated with the
UCNP@PP–Ce6 nanoparticles for 4 h. And then cells were
imaged in the bright field and the fluorescence field using a
confocal microscope. The green fluorescence from the Ce6 was
observed at the cytoplasmic region of the cells (Fig. 6b). These
results show the successful uptake of Ce6-loaded UCNP@PP
nanoparticles by HeLa cell.
3.6 In vitro PDT effects on cancer cells
Finally, the photodynamic effect of UCNP@PP–Ce6 on QGY-
7703 cells was investigated. After incubation with 100 mg ml1
of UCNP@PP–Ce6 for 12 h, the nanoparticle-treated cells were
exposed to NIR light (980 nm laser) at a relatively low density of
1.5 W cm2 for 5 min. The cells were then stained with trypan
blue, a vital dye that only stains the cell when its membrane
is damaged. There has been no cell death observed in all
the control experiments (Fig. S5, ESI† and Fig. 7a), however
significant cell death is observed for 7703 cells incubated with
UCNP@PP–Ce6 after exposure to the NIR light for 5 min
(Fig. 7b). Furthermore the cells with UCNP@PP did not show
obvious damage with or without NIR light irradiation (Fig. S4c
and d, ESI†). These results confirmed the PDT effects induced
by the presence of Ce6 under NIR light irradiation. The absorbance
of Ce6 at approximately 660 nm overlaps with the red emission
peak of the upconversion NaYF4:Yb, Tm–NaYF4:Yb, Er nano-
crystals, thus the light emitted by the nanocrystals activates Ce6
to release singlet oxygen species to kill the cancer cell.
4. Conclusions
In summary, core–shell structured NaYF4:Yb
3+, Tm3+–NaYF4:Yb
3+,
Er3+ upconversion nanocrystals (UCNPs) were synthesized with
Tm3+ and Er3+ doped in the core and the shell, respectively,
using a modified thermal decomposition method. Both NIR
emission from Tm3+ and visible emissions from Er3+ were
observed from the core–shell nanocrystals under the irradiation
of a 980 nm NIR laser. After surface modification with PEG–
phospholipid (PP), this water-soluble UCNP@PP could be used
as a potential bio-label for in vitro and in vivo NIR optical
imaging, and as a promising photosensitizer carrier for intra-
cellular PDT. The prominent PDT effects of the UCNP@PP–Ce6
on the 7703 liver cancer cells demonstrate the promising
prospect of UCNP@PP as a multifunctional nanoplatform for
simultaneous diagnosis and therapy.
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100 mg ml1 UCNP@PP–Ce6 and without 980 nm laser exposure; (b) with
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